Related Experiment Video
Updated: Jun 3, 2026
08:57
Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models
Published on: May 17, 2024
Primary synovial sarcoma of the heart
Lei Zhang1, Jianjun Qian, Zhongdong Li
1Department of Cardiothoracic Surgery, Jinling Hospital, School of Clinical Medicine, Nanjing University, Jiangsu Province, China.
Cardiology Journal
|March 25, 2011
Summary
Primary cardiac synovial sarcoma is a rare malignancy with poor outcomes. Early diagnosis via imaging and genetic testing, coupled with surgery and adjuvant therapies, is crucial for improving patient prognosis.
Area of Science:
- Cardiovascular Pathology
- Oncology
- Medical Genetics
Background:
- Primary synovial sarcoma of the heart is an exceptionally rare cardiac malignancy, constituting approximately 5% of all heart tumors.
- Historically, this condition has been associated with a dismal prognosis, with limited reported cases showing favorable outcomes.
Observation:
- This uncommon malignancy often presents with nonspecific symptoms, leading to diagnostic delays.
- Advanced imaging modalities such as echocardiography, CT, and MRI are essential for tumor characterization.
- The pathognomonic chromosomal translocation t(X; 18) is a critical diagnostic marker.
Findings:
- Surgical intervention is imperative for improving the prognosis of cardiac synovial sarcoma.
- Adjuvant therapies, including chemotherapy and potentially genetic or targeted treatments, play a vital role in prolonging survival.
- The identification of the t(X; 18) abnormality is key to increasing recognition and understanding of this tumor.
Implications:
- Future therapeutic strategies should focus on developing novel agents and leveraging genetic insights for more targeted treatments.
- Further research into the molecular mechanisms driven by the t(X; 18) translocation may unlock more effective therapeutic avenues.
- Multidisciplinary management involving surgical resection and adjuvant therapies offers the best current approach to managing this rare cardiac tumor.
Related Concept Videos
01:03Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
01:03Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
01:25Cardiomyopathy I: Introduction and Classification
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:27Anatomy of the Heart
The human heart is made up of three layers of tissue that are surrounded by the pericardium, a membrane that protects and confines the heart. The outermost layer, closest to the pericardium, is the epicardium. The pericardial cavity separates the pericardium from the epicardium. Beneath the epicardium is the myocardium, the middle layer, and the endocardium, the innermost layer. There are four chambers of the heart: the right atrium, the right ventricle, the left atrium, and the left ventricle.